Rhythmic expression of DEC2 protein in vitro and in vivo

Introduction

Circadian rhythms are important for living mammals and are predominantly regulated by clock genes (1–3). Disturbance of circadian rhythms may be associated with sleep disorder, depression, diabetes and cancer (4–9). A growing number of studies have shown that the abnormalities of clock gene expression are associated with psychiatric disorders, tumor progression, myocardial infarction, metabolic syndrome and immune disorder (10–16).

The transcription factor DEC2 is important in the circadian rhythm, hypoxia response, differentiation and tumor progression (3,10,11,17–24). While DEC1 and DEC2 mRNA indicate a rhythmic expression in the suprachiasmatic nucleus (SCN), peripheral tissues, tumor cells and human mesenchymal stem cells (MSCs) (3,17,18,21,25–29), whether DEC2 protein has rhythmic expression remains unclear. It seems likely that the rhythmic patterns of DEC1 and DEC2 are different in cell types (26), and what influences of DEC2 rhythmic expression under cell culture is poorly understood.

AMP-activated protein kinase (AMPK) is a sensor of cellular energy status (30,31). AMPK activity (phosphorylation of AMPK or pAMPK) is important in glucose metabolism, cell death and tumor progression (32,33). Rhythmic AMPK activity was observed in mice and mouse embryonic fibroblasts (MEFs) and a loss of AMPK disturbed the rhythmic expression of clock genes Bmal1 and Per2 (34,35). DEC1 protein and AMPK activity are known to have rhythmic expression in mouse liver, and DEC1 negatively regulates AMPK activity (36). However, the association between DEC2 and AMPK activity is unclear.

In the present study, we investigated the rhythmic expression of DEC2 protein and AMPK activity in mouse liver, lung and muscle, MCF-7 and U2OS human cancer cell lines, and MEF. These results may contribute to understanding of the biological functions of DEC2 and AMPK activity in various cell types.

Materials and methods

Animals

Six to 8-week-old male C57BL/6 mice were housed as previously described (26). The light in the mouse room was turned on at 7:00 a.m. (ZT 0 corresponds to 7:00 a.m., lights turned on) and turned off at 7:00 p.m. (ZT 12). Mice were entrained on a 12-h light/dark cycle for 2 weeks prior to experiments. Tissue samples were extracted from the liver, lungs and muscles of mice and were subjected to western blot analysis. Animal care and use procedures were approved by the Institutional Animal Care and Use Committee at the UNC at Chapel Hill Animal Care Facility.

DEC2 knockout mice

DEC2−/− mice were generated by inGenious Targeting Laboratory, Inc. (Stony Brook, NY, USA). Briefly, the 2.8-kb BsiEI-AlwNI genomic region of DEC2 that spans exons 1–5, including the entire coding region, was replaced with a Neo cassette. The knockout mice were backcrossed onto a C57BL/6 background. Six to 8-week-old mice were housed as above, and tissues were prepared for immunohistochemistry.

Immunohistochemistry

pAMPK immunoreactivity in mouse liver and lung tissues were evaluated using serial deparaffinized sections. Immunohistochemistry was performed using a Discovery auto-stainer machine with automated protocols (Ventana Medical Systems, Inc., Tucson, AZ, USA; Roche, Mannheim, Germany). Sections were reacted with pAMPK antibody (1:100) for 2 h.

Cell culture and treatment

The MCF-7 human breast cancer and U2OS human osteosarcoma cell lines were obtained from the American Type Culture Collection (ATCC; Manassas, VA, USA). Primary MEF were prepared as previously described (37). The cells were cultured in Dulbecco's modified Eagle's medium (DMEM) (Sigma Chemical Co., St. Louis, MO, USA) or in DMEM without glucose (Gibco-Life Technologies, Grand Island, NY, USA) supplemented with 10% fetal bovine serum at 37°C in a humidified atmosphere of 95% air and 5% CO2. The medium change (fresh medium) was performed at 0 h, and the cells were cultured for 48 or 60 h without further medium change.

Antibodies

The following commercial antibodies were purchased: actin (mouse monoclonal, Ab-1; Millipore Corp., Billerica, MA, USA), DEC1 (rabbit polyclonal, NB100-1800; Novus Biologicals, Littleton, CO, USA), DEC2 (mouse monoclonal, E-4; Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA), pAMPK (rabbit monoclonal, 40H9) and AMPK (rabbit monoclonal, 23A3) (both from Cell Signaling Technology, Inc., Danvers, MA, USA).

Western blotting

The cells treated with a medium change, or glucose-depleted medium were lysed using 0.5% NP-40 lysis buffer for western blot analysis. The total cell lysates were run on 12.5% SDS-polyacrylamide gel followed by western blotting using the standard procedure. The WesternBright ECL and WesternBright Sirius kits (BioExpress, Kaysville, UT, USA) were used for antibody detection.

Data quantification

The intensities of the bands detected in Western blotting were quantified using Java based free software ImageJ (NIH, Bethesda, MD, USA).

Results

Rhythmic expression of DEC2 protein and pAMPK in mouse liver, lung and muscle

To investigate whether DEC2 protein and pAMPK showed a rhythmic expression in vivo, we performed western blot analysis using samples prepared from mouse liver, lungs and muscles at indicated ZTs. The levels of DEC2 protein and pAMPK showed a rhythmic expression (Fig. 1). A high level of total AMPK was detected in the liver, lungs and muscles at each time-point. These results suggested that DEC2 protein and AMPK activity have a rhythmic expression ubiquitously in various tissues.

Figure 1. Rhythmic expression of DEC2 protein in mice. (A) Mice were housed under light-dark conditions as described in Materials and methods. Liver, lung and muscle samples were collected from the mice and subjected to western blotting for DEC2, pAMPK, AMPK and actin levels. One representative sample from two independent experiments with similar results is shown. (B) The intensities of DEC2, pAMPK and AMPK bands were quantified and divided by that of actin. AMPK, AMP-activated protein kinase.

Rhythmic expression of DEC2 protein by medium change in U2OS and MCF-7 cells

To determine whether medium change affected the rhythmic expression, we examined DEC2 protein levels in U2OS and MCF-7 cells. DEC2 protein levels in U2OS cells increased slightly at 18 and 24 h and the highest levels were observed at 42 and 48 h after medium change (Fig. 2A and B). DEC2 protein levels in MCF-7 cells strongly increased at 24 h and at 42–60 h after medium change (Fig. 2C and D). These results suggested that DEC2 protein is produced in a rhythmic manner by medium change. In addition, pAMPK in U2OS and MCF-7 cells increased in a time-dependent manner until 60 h. A high level of total AMPK was observed in the MCF-7 and U2OS cells with a little alteration by medium change at each time-point. No rhythmic patterns were observed in pAMPK and total AMPK in the two cell lines.

Figure 2. Rhythmic expression of DEC2 protein in U2OS and MCF-7 cells by the medium change. (A and B) U2OS and (C and D) MCF-7 cells were cultured and subjected to a medium change. The cells were sampled at 0 and 3 h and then every 6 h until 60 h. Samples were subjected to western blotting for DEC2, pAMPK, AMPK and actin levels. One representative sample from two independent experiments with similar results is shown. The intensities of DEC2, pAMPK and AMPK bands were quantified as described above. AMPK, AMP-activated protein kinase.

Rhythmic expression of DEC2 protein by medium change in MEF

To investigate whether DEC2 protein was produced in a rhythmic manner in MEF, MEF was treated with medium change or glucose-depleted medium. Although DEC2 protein levels in MEF were decreased after medium change or glucose-depleted medium treatment (Fig. 3), rhythmic protein production was observed at 24 and 48 h after medium change. However, an obvious rhythmic pattern of DEC2 protein was not observed under the condition of glucose-depleted medium.

Figure 3. Rhythmic expression of DEC2 protein in MEF is decreased by medium change. (A) MEF were cultured and subjected to medium change or glucose-depleted medium. The cells were sampled at 0 and 6 h and then every 6 h until 48 h from the time of the medium change (0 h) or glucose-depleted medium. Samples were subjected to western blotting for DEC1, DEC2, pAMPK, AMPK and actin levels. One representative sample from two independent experiments with similar results is shown. (B) The intensities of DEC1, DEC2, pAMPK and AMPK bands were quantified as described above. MEF, mouse embryonic fibroblast; AMPK, AMP-activated protein kinase.

On the other hand, a rhythmic expression of pAMPK was evident in MEF following treatment with medium change and glucose-depleted medium, whereas total AMPK was constitutively produced without a rhythmic pattern under these conditions. In addition, DEC1 protein levels began to decrease gradually ~18 h after treatment with medium change or glucose-depleted medium. Thus, DEC1 in MEF had no rhythmic expression under these conditions.

AMPK activity may be suppressed by DEC2

In a recent study, we reported that DEC1 negatively regulates AMPK activity (36). To investigate whether DEC2 regulated AMPK activity, we performed immunohistochemical detection of pAMPK in the liver and lung of DEC2 knockout mice using pAMPK antibody. The representative images of pAMPK immunoreactivity are shown in Fig. 4. Strong pAMPK was detected in the cytoplasm of the hepatocyte and sinusoid, and in the cytoplasm of the alveolar epithelial and stromal cells of DEC2 knockout mice compared with those of wild-type mice. It is therefore possible that DEC2 may suppress AMPK activity.

Figure 4. pAMPK immunoreactivity was strongly detected in DEC2 knockout mice tissues. Strong pAMPK immunoreactivity was detected in the liver and lung of DEC2 KO mice compared with WT mice. AMPK, AMP-activated protein kinase; KO, knockout; WT, wild-type.

Discussion

In the present study, we used differentiated and undifferentiated cells and tissues to compare the rhythmic expression of DEC2 and AMPK activity, to understand the biological functions of DEC2 in various cell types. DEC2 mRNA is known to show a rhythmic expression in SCN, kidneys, liver, muscles, sarcoma cells and hepatocellular carcinoma HepG2 cells (3,21,25,38,39). However, there are no studies available on the rhythmic expression of DEC2 protein. Therefore, we focused on the expression levels of DEC2 protein. DEC1 was previously shown to have an inverted rhythmic pattern of AMPK activity in mouse liver and heart, binding to the E-box of the LKB1 promoter (36). Thus, DEC1 negatively regulates AMPK activity via LKB1 (36). DEC2 binds to the E-boxes of the DEC1, PER1, PER2, MyoD, sterol regulatory element-binding protein-1c (SREBP-1c) and DNA mismatch repair (MMR) promoter (3,18,40–43). The rhythmic expression of DEC2 in lung had an inverted pattern of pAMPK immunoreactivity. In addition, strong immunostaining of pAMPK was detected in DEC2 knockout mice tissues compared with those of wild-type mice. These results suggest that DEC2 regulates the metabolism of various tissues via AMPK activity.

Medium change in cultured rat-1 fibroblasts induces the rhythmic expression of PER2 and BMAL1, suggesting that medium change resets the circadian clock in cells (44). However, whether DEC2 expression is affected by medium change remains unclear. Therefore, we examined whether DEC2 has a rhythmic expression in cultured cells by medium change. As the endogenous expression of DEC2 was low in fibroblasts, we used two cancer cell-lines (MCF-7 and U2OS), as previously described (21,45,46). We found that DEC2 protein levels showed a rhythmic expression by medium change. These results suggest that medium change induces endogenous DEC2 expression in a rhythmic manner, resetting the circadian clock in U2OS and MCF-7 cells.

We also found that pAMPK increased in cultured cells at a later stage after medium change, although a rhythmic expression was not observed. Considering that cancer cells consume much glucose compared with normal cells, an increase of pAMPK observed in cancer cells may be associated with glucose condition where pAMPK is known to be induced by glucose depletion (32). Of note, pAMPK in MEF showed a rhythmic expression under the condition of medium change or glucose-depleted medium. This result suggests that medium change reset the circadian clock, inducing rhythmic expression. It is possible that the effect on the reset of the circadian clock by medium change may differ in cell types. Future studies are required to clarify the different effects on other types of cells.

The rhythmic expression of DEC2 protein in MEF was not clear compared with that in U2OS and MCF-7 cells. Since MEF are undifferentiated cells, it is possible that DEC2 may show a rhythmic expression in differentiated cells, although the rhythmic expression of DEC2 may decrease in undifferentiated cells.

In conclusion, we have demonstrated a rhythmic expression of DEC2 protein. In addition, pAMPK in MEF has shown the rhythmic expression under the condition of medium change or glucose-depleted medium. These results provide new aspects of DEC2 protein and AMPK activity in culture cells.

Acknowledgements

We would like to thank Shenli Hew from the Department of Clinical Research Center, Wakayama Medical University, for proofreading and editing the manuscript. The present study was supported by grants (CA100302) from the NIH awarded to Y.Z., a Grant-in-Aid for Scientific Research (24590488) from the Ministry of Education, Science, Sport, and Culture of Japan awarded to Y.M., and from the Special Research Project of Wakayama Medical University School of Medicine awarded to F.S.

References